Gene therapy against restenosis - which gene to choose ?
This article was originally published in Clinica
Promising strategies of gene therapy to prevent restenosis after angioplasty are "likely to be successful provided they are targeted against stent-related restenosis", says a group from Inserm, Paris (France), in The Lancet (December 2nd).
You may also be interested in...
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.
Correvio’s attempt to move vernakalant from 'clinical hold' to 'FDA approved' was a huge long shot. But the advisory committee vote – and looming FDA rejection – are another indication that real-world data is not a panacea.